<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04060797</url>
  </required_header>
  <id_info>
    <org_study_id>ED-PAD</org_study_id>
    <nct_id>NCT04060797</nct_id>
  </id_info>
  <brief_title>Endovascular Denervation in Patients With Peripheral Arterial Disease</brief_title>
  <official_title>Endovascular Denervation in Patients With Peripheral Arterial Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhongda Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhongda Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sympathetic overactivity partly promotes the development of peripheral artery disease which
      mainly leads to ischemia of the lower limbs. Endovascular arterial denervation (ED) is a
      minimally invasive technique which could deliver Radiofrequency energy by a multi-electrode
      catheter to the Lower limb artery to restore Sympathetic activity. The purpose of this study
      is to evaluate the effects of multi-electrode radiofrequency ablation system on lower limb
      ischemia with PAD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peripheral arterial disease(PAD) show insufficient blood supply of diseased limbs, which
      causes intermittent claudication of lower limbs, reduced skin temperature, pain, and chronic
      progressive disease that still produces ulcer or necrosis. Some clinical studies have shown
      Sympathetic overactivity in the lower arterial ischemic disease. The multi-electrode
      radiofrequency ablation system can significantly reduce the excitability of sympathetic
      nerve, restore the normal response of sympathetic nerve, relieve the pain and discomfort of
      patients, effectively improve the symptoms of lower limb ischemia, and improve the quality of
      life of patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 13, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ischemia relief</measure>
    <time_frame>from baseline to 1 months after procedure</time_frame>
    <description>Changes of the ankle brachial index(ABI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ischemia relief</measure>
    <time_frame>from baseline to 3months after procedure</time_frame>
    <description>Changes of the ankle brachial index(ABI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain relief</measure>
    <time_frame>from baseline to 3 months after procedure</time_frame>
    <description>Changes of the numeric rating scale ( NRS) scores</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>PAD</condition>
  <arm_group>
    <arm_group_label>endovascular denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>endovascular denervation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>endovascular denervation</intervention_name>
    <description>multi-electrode catheter-based endovascular denervation</description>
    <arm_group_label>endovascular denervation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 75 years

          -  Patients with established PAD with Rutherford Grade2-6

        Exclusion Criteria:

          -  pregnant or intent to become pregnant

          -  Orthostatic hypotension

          -  acute or severe systemic infection

          -  uncorrected coagulation dysfunction

          -  renal dysfunction

          -  Patients that have allergy to contrast agent and nitinol

          -  Myocardial infarction, unstable angina pectoris, coronary bypass or percutaneous
             angioplasty within 3 months before inclusion

          -  Cerebrovascular accidents and alimentary tract hemorrhage within 3 months before
             inclusion

          -  participants who are not suitable to be enrolled into the study assessed bythe
             researchers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gao-Jun Teng, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongda Hospital Southeast University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gao-Jun Teng, MD</last_name>
    <phone>+86 25 83272121</phone>
    <email>gjteng@seu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guo-Feng Zhao, MD</last_name>
    <phone>+86-15951804797</phone>
    <email>dreamboyseu@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongda Hospital, Southeast University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gao-Jun Teng, MD</last_name>
      <phone>+86 25 83272121</phone>
      <email>gjteng@seu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Guo-Feng Zhao, MD</last_name>
      <phone>+86-15951804797</phone>
      <email>dreamboyseu@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 16, 2019</study_first_submitted>
  <study_first_submitted_qc>August 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2019</study_first_posted>
  <last_update_submitted>August 16, 2019</last_update_submitted>
  <last_update_submitted_qc>August 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zhongda Hospital</investigator_affiliation>
    <investigator_full_name>Gao-jun Teng</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

